FI952650A - 3-heteroalifatyyli- ja hetero(aryyli)alifatyyli-2(1H)-kinolonijohdannaiset - Google Patents
3-heteroalifatyyli- ja hetero(aryyli)alifatyyli-2(1H)-kinolonijohdannaiset Download PDFInfo
- Publication number
- FI952650A FI952650A FI952650A FI952650A FI952650A FI 952650 A FI952650 A FI 952650A FI 952650 A FI952650 A FI 952650A FI 952650 A FI952650 A FI 952650A FI 952650 A FI952650 A FI 952650A
- Authority
- FI
- Finland
- Prior art keywords
- heteroaliphatyl
- aliphatyl
- hetero
- aryl
- quinolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH173294 | 1994-06-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI952650A0 FI952650A0 (fi) | 1995-05-31 |
| FI952650A true FI952650A (fi) | 1995-12-03 |
Family
ID=4217306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI952650A FI952650A (fi) | 1994-06-02 | 1995-05-31 | 3-heteroalifatyyli- ja hetero(aryyli)alifatyyli-2(1H)-kinolonijohdannaiset |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5633379A (fi) |
| EP (1) | EP0685466A1 (fi) |
| JP (1) | JPH0841027A (fi) |
| KR (1) | KR960000868A (fi) |
| CN (1) | CN1120538A (fi) |
| AU (1) | AU2033695A (fi) |
| BR (1) | BR9502647A (fi) |
| CA (1) | CA2150645A1 (fi) |
| FI (1) | FI952650A (fi) |
| HU (1) | HUT72608A (fi) |
| IL (1) | IL113975A0 (fi) |
| NO (1) | NO952171L (fi) |
| NZ (1) | NZ272258A (fi) |
| RU (1) | RU95109098A (fi) |
| ZA (1) | ZA954507B (fi) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2943725B2 (ja) | 1996-01-17 | 1999-08-30 | 大日本インキ化学工業株式会社 | キノリノン誘導体及びそれを有効成分とする抗アレルギー剤 |
| DE19601782A1 (de) * | 1996-01-19 | 1997-07-24 | Merck Patent Gmbh | Chinolin-2-(1H)one |
| EP0869122B1 (en) * | 1997-03-31 | 2002-12-04 | Korea Research Institute Of Chemical Technology | Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof |
| KR100301129B1 (ko) * | 1997-11-06 | 2001-11-30 | 김충섭 | 3-(치환-페닐티오)-4-하이드록시퀴놀린-2(1h)-온 유도체 및 그들의 제조방법 |
| AU2002250256B2 (en) * | 2001-03-08 | 2008-04-03 | Emory University | pH-dependent NMDA receptor antagonists |
| US6689791B2 (en) * | 2002-03-01 | 2004-02-10 | R. T. Alamo Ventures I, Llc | Carboxylated heterocyclic compounds and methods of synthesis |
| MX2009014216A (es) * | 2007-06-29 | 2010-07-05 | Univ Emory | Antagonistas del receptor nmda para neuroproteccion. |
| CN103508950B (zh) * | 2012-06-25 | 2016-04-20 | 南开大学 | 含亚胺结构的4-羟基-2-喹啉酮类化合物及其制备和应用 |
| AU2015308350B2 (en) | 2014-08-29 | 2020-03-05 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
| KR101847567B1 (ko) | 2015-12-24 | 2018-04-10 | 주식회사 포스코 | 미세하고 균일한 도금 조직을 갖는 도금 강판 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3847927A (en) * | 1972-12-20 | 1974-11-12 | Dow Chemical Co | Sulfur-containing hydroxypyridones |
| US4127574A (en) * | 1976-03-01 | 1978-11-28 | Sandoz, Inc. | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones |
| US4124587A (en) * | 1976-03-01 | 1978-11-07 | Sandoz, Inc. | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones |
| DE69113115T2 (de) * | 1990-05-31 | 1996-06-13 | Merck Sharp & Dohme | Dioxo-tetrahydrochinolinderivate. |
| GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
| GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| SE469368B (sv) * | 1991-10-09 | 1993-06-28 | Kabi Pharmacia Ab | Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) |
| GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125485D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-05-23 EP EP95810344A patent/EP0685466A1/de not_active Withdrawn
- 1995-05-26 AU AU20336/95A patent/AU2033695A/en not_active Abandoned
- 1995-05-29 RU RU95109098/04A patent/RU95109098A/ru unknown
- 1995-05-31 NZ NZ272258A patent/NZ272258A/en unknown
- 1995-05-31 CA CA002150645A patent/CA2150645A1/en not_active Abandoned
- 1995-05-31 FI FI952650A patent/FI952650A/fi not_active Application Discontinuation
- 1995-06-01 KR KR1019950014478A patent/KR960000868A/ko not_active Application Discontinuation
- 1995-06-01 CN CN95106179A patent/CN1120538A/zh active Pending
- 1995-06-01 IL IL11397595A patent/IL113975A0/xx unknown
- 1995-06-01 NO NO952171A patent/NO952171L/no unknown
- 1995-06-01 HU HU9501598A patent/HUT72608A/hu unknown
- 1995-06-01 ZA ZA954507A patent/ZA954507B/xx unknown
- 1995-06-01 US US08/456,358 patent/US5633379A/en not_active Expired - Fee Related
- 1995-06-02 BR BR9502647A patent/BR9502647A/pt not_active Application Discontinuation
- 1995-06-02 JP JP7136724A patent/JPH0841027A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUT72608A (en) | 1996-05-28 |
| CN1120538A (zh) | 1996-04-17 |
| KR960000868A (ko) | 1996-01-25 |
| AU2033695A (en) | 1995-12-14 |
| CA2150645A1 (en) | 1995-12-03 |
| EP0685466A1 (de) | 1995-12-06 |
| IL113975A0 (en) | 1995-10-31 |
| RU95109098A (ru) | 1997-03-10 |
| JPH0841027A (ja) | 1996-02-13 |
| FI952650A0 (fi) | 1995-05-31 |
| NO952171L (no) | 1995-12-04 |
| BR9502647A (pt) | 1996-04-23 |
| US5633379A (en) | 1997-05-27 |
| NZ272258A (en) | 1996-12-20 |
| HU9501598D0 (en) | 1995-07-28 |
| NO952171D0 (no) | 1995-06-01 |
| ZA954507B (en) | 1996-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO932176D0 (no) | Kinolin-, naftyridin- og pyridobenzoksazinderivater | |
| DE69634416D1 (de) | Chinolin-derivate | |
| NO20013003D0 (no) | Kinolin-derivater | |
| ATE228505T1 (de) | Chinolinderivate | |
| ATE250036T1 (de) | Chinolinderivate | |
| DE69132519T2 (de) | Chinolinderivate | |
| ATE229005T1 (de) | Chinolinderivate | |
| BR9507553A (pt) | Novos antimicrobianos de quinolina 5-(amido n- heterossubstituída) | |
| FI940216A0 (fi) | Kinoloni- ja naftyridonikarboksyylihappojohdannaiset | |
| NO985227L (no) | Alkylaminobenzothiazol og -benzoksazol - derivater | |
| FI952650A0 (fi) | 3-heteroalifatyyli- ja hetero(aryyli)alifatyyli-2(1H)-kinolonijohdannaiset | |
| BR9707027A (pt) | Quinolin-2(1h)-onas | |
| NO930520D0 (no) | Bifenyl-substituerte kinolinderivater | |
| FI970110A (fi) | Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia | |
| ITMI941099A0 (it) | Derivati chinolinici | |
| DE69709802D1 (de) | Amythiamicin Amid-Derivate | |
| DE69711853T2 (de) | Pyridincarboxamid-derivate | |
| DE69715979D1 (de) | Chinolinderivate und ihre Anwendung | |
| BR1100102A (pt) | Fungicidas de quinolina e cinolina | |
| KR920701161A (ko) | 4(1h)퀴놀론 유도체 | |
| KR970001328A (ko) | 치환된 퀴놀린 제초제 중간체 및 이의 제조 방법 | |
| KR960019411U (ko) | 착탈식 캠코더 | |
| ITMI941098A0 (it) | Derivati chinolinici | |
| KR950028980U (ko) | 증폭 스피커 | |
| ZA955344B (en) | Aryl and heteroaryl alkoxynaphthalene derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |
|
| FD | Application lapsed |